146 related articles for article (PubMed ID: 16565468)
21. Activation of prostaglandin E receptor EP4 subtype suppresses food intake in mice.
Ohinata K; Suetsugu K; Fujiwara Y; Yoshikawa M
Prostaglandins Other Lipid Mediat; 2006 Oct; 81(1-2):31-6. PubMed ID: 16997129
[TBL] [Abstract][Full Text] [Related]
22. Cyclooxygenase-2-derived prostaglandin e2 protects mouse embryonic stem cells from apoptosis.
Liou JY; Ellent DP; Lee S; Goldsby J; Ko BS; Matijevic N; Huang JC; Wu KK
Stem Cells; 2007 May; 25(5):1096-103. PubMed ID: 17234991
[TBL] [Abstract][Full Text] [Related]
23. Prostaglandin receptor EP2 is responsible for cyclooxygenase-2 induction by prostaglandin E2 in mouse skin.
Ansari KM; Sung YM; He G; Fischer SM
Carcinogenesis; 2007 Oct; 28(10):2063-8. PubMed ID: 17277233
[TBL] [Abstract][Full Text] [Related]
24. Prostaglandin EP2 and EP4 receptors modulate expression of the chemokine CCL2 (MCP-1) in response to LPS-induced renal glomerular inflammation.
Zahner G; Schaper M; Panzer U; Kluger M; Stahl RA; Thaiss F; Schneider A
Biochem J; 2009 Aug; 422(3):563-70. PubMed ID: 19570035
[TBL] [Abstract][Full Text] [Related]
25. Comparison of nociceptive behavior in prostaglandin E, F, D, prostacyclin and thromboxane receptor knockout mice.
Popp L; Häussler A; Olliges A; Nüsing R; Narumiya S; Geisslinger G; Tegeder I
Eur J Pain; 2009 Aug; 13(7):691-703. PubMed ID: 18938093
[TBL] [Abstract][Full Text] [Related]
26. Effects of prostanoid EP agonists on mouse intraocular pressure.
Saeki T; Ota T; Aihara M; Araie M
Invest Ophthalmol Vis Sci; 2009 May; 50(5):2201-8. PubMed ID: 19117925
[TBL] [Abstract][Full Text] [Related]
27. Specific components of prostanoid-signaling pathways are present in non-small cell lung cancer cells.
Kreutzer M; Fauti T; Kaddatz K; Seifart C; Neubauer A; Schweer H; Kömhoff M; Müller-Brüsselbach S; Müller R
Oncol Rep; 2007 Aug; 18(2):497-501. PubMed ID: 17611676
[TBL] [Abstract][Full Text] [Related]
28. Prostaglandin E2 at new glance: novel insights in functional diversity offer therapeutic chances.
Legler DF; Bruckner M; Uetz-von Allmen E; Krause P
Int J Biochem Cell Biol; 2010 Feb; 42(2):198-201. PubMed ID: 19788928
[TBL] [Abstract][Full Text] [Related]
29. Cyclooxygenases, peroxide tone and the allure of fish oil.
Smith WL
Curr Opin Cell Biol; 2005 Apr; 17(2):174-82. PubMed ID: 15780594
[TBL] [Abstract][Full Text] [Related]
30. Prostaglandin E2 and the EP receptors in malignancy: possible therapeutic targets?
O'Callaghan G; Houston A
Br J Pharmacol; 2015 Nov; 172(22):5239-50. PubMed ID: 26377664
[TBL] [Abstract][Full Text] [Related]
31. Coupling between cyclooxygenases and terminal prostanoid synthases.
Ueno N; Takegoshi Y; Kamei D; Kudo I; Murakami M
Biochem Biophys Res Commun; 2005 Dec; 338(1):70-6. PubMed ID: 16140261
[TBL] [Abstract][Full Text] [Related]
32. Contribution of the prostaglandin E2/E-prostanoid 2 receptor signaling pathway in abscess formation in rat zymosan-induced pleurisy.
Inada T; Arai K; Kawamura M; Hatanaka K; Sato Y; Noshiro M; Harada Y
J Pharmacol Exp Ther; 2009 Dec; 331(3):860-70. PubMed ID: 19726696
[TBL] [Abstract][Full Text] [Related]
33. PGE(2) induces COX-2 expression in podocytes via the EP(4) receptor through a PKA-independent mechanism.
Faour WH; Gomi K; Kennedy CR
Cell Signal; 2008 Nov; 20(11):2156-64. PubMed ID: 18762248
[TBL] [Abstract][Full Text] [Related]
34. Pharmacological and molecular characterization of the mechanisms involved in prostaglandin E2-induced mouse paw edema.
Claudino RF; Kassuya CA; Ferreira J; Calixto JB
J Pharmacol Exp Ther; 2006 Aug; 318(2):611-8. PubMed ID: 16644903
[TBL] [Abstract][Full Text] [Related]
35. EP2 and EP4 receptors differentially mediate MAPK pathways underlying anabolic actions of prostaglandin E2 on bone formation in rat calvaria cell cultures.
Minamizaki T; Yoshiko Y; Kozai K; Aubin JE; Maeda N
Bone; 2009 Jun; 44(6):1177-85. PubMed ID: 19233324
[TBL] [Abstract][Full Text] [Related]
36. Activation of brain prostanoid EP3 receptors via arachidonic acid cascade during behavioral suppression induced by Delta8-tetrahydrocannabinol.
Yamaguchi T; Kubota T; Watanabe S; Yamamoto T
J Neurochem; 2004 Jan; 88(1):148-54. PubMed ID: 14675158
[TBL] [Abstract][Full Text] [Related]
37. Cyclooxygenase isozymes: the biology of prostaglandin synthesis and inhibition.
Simmons DL; Botting RM; Hla T
Pharmacol Rev; 2004 Sep; 56(3):387-437. PubMed ID: 15317910
[TBL] [Abstract][Full Text] [Related]
38. Molecular cloning and characterization of chicken prostaglandin E receptor subtypes 2 and 4 (EP2 and EP4).
Kwok AH; Wang Y; Wang CY; Leung FC
Gen Comp Endocrinol; 2008 Jun; 157(2):99-106. PubMed ID: 18486942
[TBL] [Abstract][Full Text] [Related]
39. Coxibs and Alzheimer's disease: should they stay or should they go?
Firuzi O; Praticò D
Ann Neurol; 2006 Feb; 59(2):219-28. PubMed ID: 16402383
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of both COX-1 and COX-2 and resulting decrease in the level of prostaglandins E2 is responsible for non-steroidal anti-inflammatory drug (NSAID)-dependent exacerbation of colitis.
Tanaka K; Suemasu S; Ishihara T; Tasaka Y; Arai Y; Mizushima T
Eur J Pharmacol; 2009 Jan; 603(1-3):120-32. PubMed ID: 19101538
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
